Significant survival gains from neoadjuvant chemotherapy for high-risk soft tissue sarcoma
Tuesday, October 11, 2016 - 04:31
in Health & Medicine
Neoadjuvant chemotherapy with an anthracycline plus ifosfamide was associated with significant survival gains in patients with soft tissue sarcoma of the trunk or extremities who are at high-risk of recurrence, in an interim analysis that led to the early discontinuation of a trial.